LIVER RESEARCH AND DEVELOPMENT LIMITEDActive
Key figures
Ratios
2023/24Balance sheet structure
Filed accounts2021/22–2023/24
| 2021/22 | 2022/23 | 2023/24 | |
|---|---|---|---|
| Turnover | 361,868 | 355,063 | 473,498 |
| Cash at bank and in hand | 640,286 | 0 | 0 |
| Total assets | 640,286 | 640,286 | 277,708 |
| Total liabilities | 5,251,638 | 6,810,313 | 7,455,491 |
| Net assets / total equity | 4,279,596 | 5,483,207 | 7,177,783 |
| Average number of employees | 0 | 23 | 21 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2024The company is the wholly owned subsidiary of The Foundation for Liver Research, and its principal activity is medical research into various causes of liver damage with a view to commercial collaborations and/or development.
As described in the company's latest filed accounts.
Summary: LIVER RESEARCH AND DEVELOPMENT LIMITED
Company
LIVER RESEARCH AND DEVELOPMENT LIMITED is a private limited company registered with Companies House under company number 07944232. It was incorporated on 9 Feb 2012. Its status is active. The registered office is in London (SE5). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2023/24 (period ending 30 Jun 2024); the company files small company accounts. Turnover was £473,498. Net assets were £7,177,783, up 30.9% on the previous year. Cash at bank and in hand was £0. Total assets were £277,708 and total liabilities £7,455,491. The company had an average of 21 employees. Figures are available for 3 financial years (2021/22–2023/24).
Filing deadlines
The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 5 Apr 2027.